CN
240-286-6
Applied Filters:
Keyword:'240-286-6'
Showing 1-30 of 43 results for "240-286-6" within Technical Documents
Data Sheet - C6395 - Lot 71K8805
180 200 220 240 260 280 300 320
0
10000
20000
30000
40000
50000
60000
m/z
Abundance
43 55 67 77
91 107
121
147 159
174 193
207
231
246
Product Information Sheet - L2023
(Tokyo), 22(6),
283-286 (1969).
4. Zimmerman, U-J.P. and Schlaepfer, W.W.,
Biochemistry, 21(17), 3977-3983 (1982).
5. Knight, C.G., Biochem. J., 189(3), 447-453
(1980).
6. Zollner, H.
Complement C7 Deficient Serum (C1413)
al., J. Immunol., 121, 484 (1978).
2. Götze, O., and Müller-Eberhard, H.J., N. Engl. J.
Med., 286, 180 (1972).
RBG,MAM 06/09-1
Table 1.
The volumes indicated are an example only. Adjust the volumes
Quality Control Range Sheet- A6041-102and A6041-202
/mL
IL-2 Control 1 27 - 56 pg/mL IL-5 Control 1 67 - 140 pg/mL
Control 2 138 - 286 pg/mL Control 2
XP725 Antibody Number-Lot Number 071M4826
211 212 233 234 235 236 257 258 259 260 281 282 283 284
3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288
4.1 289 290 291 292 313 314 315 316 337 338
Viral filtration of plasma-derived human IgG
,
Washington DC (2002.)
15. A.J. DiLeo, D.A. Vacante and E.F. Deane,
Biologicals 21, 275–286. (1993).
16. Millipore Application Note, Ensuring
Regulatory Compliance: Validation of Virus
Reprint: Viral Filtration of Plasma-Derived Human IgG: A Case Study using Viresolve® NFP
Planova Workshop, Washington,
DC, 2002.
15.DiLeo AJ, Vacante DA, Deane EF, Biologicals.
1993; 21:275-286.
16.Millipore Application Note, Ensuring Regulatory
Compliance: Validation of Virus Filtration,
AN1650EN00
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
FSTL1 OSM IL-6 FGF21 Musclin
N 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46
Average 122 78 9280 1298 544958 6 7 3777 38972 1905 14632 56 643 2016 174
Brochure: Ascentis® Express Fused-Core® HPLC and UHPLC Columns
0 2 4 6
Min
1 2 3
4
5
6
78
9
10
11 12
13
1. Morphine (m/z 286)
2. Oxymorphone (m/z 302)
3. Hydromorphone (m/z 286)
4. Naloxone (m/z
Protocol- MMYOMAG-74K
Standard 2 80 240 640 800 1,280
Standard 3 400 1,200 3,200 4,000 6,400
Standard 4 2,000 6,000 16,000 20,000 32,000
Standard 5 10,000 30,000 80,000 100,000 160,000
Standard 6 50,000 150,000
Pharmaceutical impurity profiling Application guide
B
120
180
240
ns
it
y
(m
V)
y
A Im
pu
rit
y
B
0.0 90 10
1.66 90 10
1.93 75 25
5.54 65 35
Pharmaceutical Impurity Profiling Application Guide
B
120
180
240
ns
it
y
(m
V)
y
A Im
pu
rit
y
B
0.0 90 10
1.66 90 10
1.93 75 25
5.54 65 35
United States Pharmacopeia Methods Purospher®STAR Columns for Regulated Drug Analysis
Mobile phase
Chromatographic system (See Chromatography 621, System Suitability.)
Detector: UV 286 nm Column: 4.0-mm × 25-cm; packing L1
Injection size: 5 μL Flow rate: 1.0 mL/min
System suitability
Application compilation - Pharma campaign
Mobile phase
Chromatographic system (See Chromatography 621, System Suitability.)
Detector: UV 286 nm Column: 4.0-mm × 25-cm; packing L1
Injection size: 5 μL Flow rate: 1.0 mL/min
System suitability
Packaging portfolio for chemicals: A selection of Data Sheets
Material: HDPE, white
Nominal volume: 13 L
Weight: 860 g
Diameter: 320 mm
Height: 286 mm
PE pail lid
Material: HDPE, blue
Diameter x height: 324 mm x 63 mm
Chrombook (WEB-Version)
Lycine 100 ppm
6. Threonine 100 ppm
Courtesy of Gora Sharangi, Merck India Application Lab
www.merck-chemicals.com/analytical-hplc
An
al
yt
ic
al
H
PL
C
286
SeQuant® ZIC
Biologics 31.1
its body weight is water, the volume of distribution will be approximately 140 ml. In this case 240 nM =
240 nmoles/liter = 124.63 mg/liter. Because the volume of distribution is about 140 ml, 124.63 x 0.140
Calbiochem Biologics 31.1
its body weight is water, the volume of distribution will be approximately 140 ml. In this case 240 nM =
240 nmoles/liter = 124.63 mg/liter. Because the volume of distribution is about 140 ml, 124.63 x 0.140
Elispot assays: state-of-the-art tools for functional analysis of cellular immunology White Paper
., and Kourilsky, P. (1999). A direct estimate of the
human αβ T cell receptor diversity. Science 286,
958–961.
11. Sun, Y., Iglesias, E., Samri, A., Kamkamidze, G., Decoville,
T., Carcelain, G.
Calbiochem Biologics 29.4
phase.
Purity: ≥95% by HPLC.
Cat. No. 553590 2 µg
Ref.: Koster, M., et al. 2003. Exp. Cell Res. 286, 321; Kalesse. M., et al. 2001. Chembiochem 2, 709;
Gerth, K., et al. 1995. J. Antibiotics 48, 973
Virus Retention Performance of Viresolve®Pro Devices under a Range of Processing Conditions
Mammalian
Viruses Using a Unique Membrane System, Part I:
Membrane Qualification. Biologicals, 21, 275-286.
12. Dishari, S.K., Venkiteshwaran, A., & Zydney, A.L.
(2015). Probing Effects of Pressure Release
Perfection in every dimension - Inorganic Reagents catalog
dosage bottle Acids 94
I Indicator solution Indicators 286
Indicators Indicators 286
Indicators for special application Indicators 286
Intermediate bulk container (IBC) Packaging 18
ISO 17025
Material Matters Vol. 1, No. 1
Avgeropoulos, A. et al. Chem. Mater. 1998, 10,
2109. (8) Chan, V. Z.-H. et al. L. Science 1999, 286, 1716. (9) Matyjaszewski,
K. Advances in Controlled/Living Radical Polymerization; American Chemical
Biologics 28.1
2000. FEBS Lett. 483, 6.
Vassar, R., and Citron, M. 2000. Neuron 27, 419.
Zhang, Z., et al. 2000. Nat. Cell Biol. 2, 463.
Haass, C., and De Stooper, B. 1999. Science 286,
916.
Sinha, S., and
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
length Pur E. coli 20 µg SGT211
12
Assay
cdc42 Activation Assay Kit ABA 1 kit 17-286
Anti-cdc42 Immunoblotting Kit WB 1 kit 17-299
Cdc42/Rac Activation Assay
Inhibitor Sourcebook 3rd Edition
, E., and Kotlyarov, A. 2007. Anti Inflam. Anti Allergy Agents in Med. Chem. 6, 85.
Wong, C. H., et al. 2005. Dev. Biol. 286, 1.
Johnson, G.L. et al. 2005. Curr. Opin. Chem. Biol. 9, 325.
Hayashi, M., and
XP725 Antibody List Lot 129K4831
ROCK-2 R8653 9475 ROCK2 P NP_004841.2 y y n/d
702 Syntaxin 8 S8945 9482 STX8 P NP_004844.1 n/d n/d y
286 FXR2 F1554 9513 FXR2 M NP_004851.2 y n/d n/d
525 p130CAS C0354 9564 BCAR1 P NP_001164185.1 y y y
445
XP725 Antibody List Lot 129K4830
ROCK-2 R8653 9475 ROCK2 P NP_004841.2 y y n/d
702 Syntaxin 8 S8945 9482 STX8 P NP_004844.1 n/d n/d y
286 FXR2 F1554 9513 FXR2 M NP_004851.2 y n/d n/d
525 p130CAS C0354 9564 BCAR1 P NP_001164185.1 y y y
445
XP725 Antibody List Lot 089K4791
ROCK-2 R8653 9475 ROCK2 P NP_004841.2 y y n/d
702 Syntaxin 8 S8945 9482 STX8 P NP_004844.1 n/d n/d y
286 FXR2 F1554 9513 FXR2 M NP_004851.2 y n/d n/d
525 p130CAS C0354 9564 BCAR1 P NP_001164185.1 y y y
445
XP725 Worksheet for Lot Number 071M4826
pSer45 C5615
283 2 2 6 3 bCatenin pSer33 C2363
284 2 2 6 4 bCatenin pSer33 C2363
dCatenin NPRAP C4864285 2 2 6 5
286 2 2 6 6 dCatenin NPRAP C4864
287 2 2 6 7 Anti CY3/5 C0992
288 2 2
Page 1 of 2